ClearPoint Neuro, Inc. (CLPT)

Market Cap	428.08M
Revenue (ttm)	34.33M +12.8%
Net Income	-23.14M
EPS	-0.83
Shares Out	29.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	422,525
Open	14.20
Previous Close	14.20
Day's Range	13.90 - 14.44
52-Week Range	9.76 - 30.10
Beta	0.92
Analysts	Strong Buy
Price Target	27.67 (+92.29%)
Earnings Date	Feb 25, 2026

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; li...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 115
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT
• Website: https://www.clearpointneuro.com

Financial Performance

In 2024, ClearPoint Neuro's revenue was $31.39 million, an increase of 31.04% compared to the previous year's $23.96 million. Losses were -$18.91 million, -14.37% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for CLPT stock is "Strong Buy." The 12-month stock price target is $27.67, which is an increase of 92.29% from the latest price.

Price Target

$27.67

(92.29% upside)

Analyst Consensus: Strong Buy